Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

This study has been completed.
Sponsor:
Collaborators:
Queen's University
Northern Ontario School of Medicine
Imperial College London
Information provided by (Responsible Party):
Simon Chiu, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT00401089
First received: November 15, 2006
Last updated: December 11, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)